PL307138A1 - Amyline antagonists and agonists - Google Patents
Amyline antagonists and agonistsInfo
- Publication number
- PL307138A1 PL307138A1 PL94307138A PL30713894A PL307138A1 PL 307138 A1 PL307138 A1 PL 307138A1 PL 94307138 A PL94307138 A PL 94307138A PL 30713894 A PL30713894 A PL 30713894A PL 307138 A1 PL307138 A1 PL 307138A1
- Authority
- PL
- Poland
- Prior art keywords
- amyline
- agonists
- antagonists
- amyline antagonists
- Prior art date
Links
- KFYRPLNVJVHZGT-UHFFFAOYSA-N Amitriptyline hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KFYRPLNVJVHZGT-UHFFFAOYSA-N 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6026593A | 1993-05-12 | 1993-05-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL307138A1 true PL307138A1 (en) | 1995-05-02 |
Family
ID=22028421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL94307138A PL307138A1 (en) | 1993-05-12 | 1994-05-11 | Amyline antagonists and agonists |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0651651A1 (en) |
| JP (1) | JPH07509008A (en) |
| AU (1) | AU669636B2 (en) |
| CA (1) | CA2139651A1 (en) |
| CZ (1) | CZ5795A3 (en) |
| HU (1) | HUT70176A (en) |
| PL (1) | PL307138A1 (en) |
| RU (1) | RU95106486A (en) |
| WO (1) | WO1994026292A1 (en) |
| ZA (1) | ZA943251B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5739106A (en) * | 1995-06-07 | 1998-04-14 | Rink; Timothy J. | Appetite regulating compositions |
| US7910548B2 (en) * | 1997-06-06 | 2011-03-22 | Amylin Pharmaceuticals, Inc. | Methods for treating obesity |
| US6087334A (en) * | 1998-08-21 | 2000-07-11 | Amylin Pharmaceuticals, Inc. | Anti-diabetic peptides |
| ATE471340T1 (en) | 2004-02-11 | 2010-07-15 | Amylin Pharmaceuticals Inc | PEPTIDES OF THE AMYLIN FAMILY, METHOD FOR THE PRODUCTION AND USE THEREOF |
| ES2640285T3 (en) | 2012-04-19 | 2017-11-02 | Novo Nordisk A/S | Human amylin analogs |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5266561A (en) * | 1988-01-11 | 1993-11-30 | Amylin Pharmaceuticals, Inc. | Treatment of type 2 diabetes mellitus |
| US5580953A (en) * | 1991-08-14 | 1996-12-03 | Amylin Pharmaceuticals, Inc. | Amylin antagonist peptides and uses therefor |
-
1994
- 1994-05-11 JP JP6525694A patent/JPH07509008A/en active Pending
- 1994-05-11 WO PCT/US1994/005282 patent/WO1994026292A1/en not_active Ceased
- 1994-05-11 CZ CZ9557A patent/CZ5795A3/en unknown
- 1994-05-11 AU AU69104/94A patent/AU669636B2/en not_active Expired - Fee Related
- 1994-05-11 PL PL94307138A patent/PL307138A1/en unknown
- 1994-05-11 RU RU95106486/14A patent/RU95106486A/en unknown
- 1994-05-11 CA CA002139651A patent/CA2139651A1/en not_active Abandoned
- 1994-05-11 ZA ZA943251A patent/ZA943251B/en unknown
- 1994-05-11 EP EP94917360A patent/EP0651651A1/en not_active Withdrawn
- 1994-05-11 HU HU9500079A patent/HUT70176A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA943251B (en) | 1995-01-16 |
| HUT70176A (en) | 1995-09-28 |
| WO1994026292A1 (en) | 1994-11-24 |
| CZ5795A3 (en) | 1995-11-15 |
| HU9500079D0 (en) | 1995-03-28 |
| RU95106486A (en) | 1996-12-27 |
| EP0651651A1 (en) | 1995-05-10 |
| AU6910494A (en) | 1994-12-12 |
| JPH07509008A (en) | 1995-10-05 |
| AU669636B2 (en) | 1996-06-13 |
| CA2139651A1 (en) | 1994-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA944338B (en) | Neuropeptide Y Antagonists and Agonists | |
| EP0723556A4 (en) | Fas antagonists and uses thereof | |
| HU9603082D0 (en) | Neurokinine (tachykinine) antagonists | |
| HU9600932D0 (en) | In-alkyl-n-arylpyrimidinamines and derivatives thereof | |
| EP1032377A4 (en) | Substituted 2-aminoacetamides and the use thereof | |
| GB9323111D0 (en) | Cryosurical probe | |
| GB9309121D0 (en) | Substituted acylating agents | |
| HU9503191D0 (en) | Adhesion-receptor antagonists | |
| EP0698040A4 (en) | Lhrh antagonists | |
| GB2281830B (en) | I/q-modulator and i/q-demodulator | |
| IL104618A (en) | Contact rail and adapter | |
| PL307138A1 (en) | Amyline antagonists and agonists | |
| IL104472A0 (en) | Substituted hexahydro-azepinones and tetrahydro-benzazepinones | |
| ZA907336B (en) | Application aid and the use thereof | |
| GB9701374D0 (en) | Purinergic agonists and antagonists | |
| GB9311423D0 (en) | New use | |
| GB9316789D0 (en) | Visosity probe | |
| GB9501907D0 (en) | Allatostatins and their use | |
| GB9306456D0 (en) | Composition and use | |
| GB9216776D0 (en) | Composition and use | |
| GB9408859D0 (en) | Composition and use | |
| GB9315783D0 (en) | Ropes and the use thereof | |
| GB9303913D0 (en) | Compound and use | |
| ZA942736B (en) | Compounds and use | |
| GB9311223D0 (en) | Compounds and use |